nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Ibandronate—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Ibandronate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Ibandronate—Rash—Melphalan—peripheral nervous system neoplasm	0.000623	0.000623	CcSEcCtD
Ibandronate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000622	0.000622	CcSEcCtD
Ibandronate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Ibandronate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Ibandronate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000617	CcSEcCtD
Ibandronate—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.000615	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Ibandronate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Ibandronate—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Ibandronate—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Ibandronate—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Ibandronate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Ibandronate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Ibandronate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Ibandronate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Ibandronate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000599	0.000599	CcSEcCtD
Ibandronate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Ibandronate—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Ibandronate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Ibandronate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Ibandronate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000592	0.000592	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Ibandronate—Infection—Etoposide—peripheral nervous system neoplasm	0.000588	0.000588	CcSEcCtD
Ibandronate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Ibandronate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Ibandronate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Ibandronate—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Ibandronate—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Ibandronate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Ibandronate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00058	0.00058	CcSEcCtD
Ibandronate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000578	0.000578	CcSEcCtD
Ibandronate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000578	0.000578	CcSEcCtD
Ibandronate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Ibandronate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Ibandronate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Ibandronate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000565	CcSEcCtD
Ibandronate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Ibandronate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Ibandronate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Ibandronate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Ibandronate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Ibandronate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Ibandronate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Ibandronate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000544	0.000544	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Ibandronate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Ibandronate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000537	0.000537	CcSEcCtD
Ibandronate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Ibandronate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Ibandronate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Ibandronate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Ibandronate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000523	CcSEcCtD
Ibandronate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Ibandronate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Ibandronate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000519	CcSEcCtD
Ibandronate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.000519	CcSEcCtD
Ibandronate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Ibandronate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Ibandronate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Ibandronate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Ibandronate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Ibandronate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Ibandronate—Pain—Etoposide—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Ibandronate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Ibandronate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Ibandronate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Ibandronate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0005	0.0005	CcSEcCtD
Ibandronate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Ibandronate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Ibandronate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Ibandronate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000486	0.000486	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Ibandronate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Ibandronate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Ibandronate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Ibandronate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Ibandronate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Ibandronate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Ibandronate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Ibandronate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Ibandronate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Ibandronate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Ibandronate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Ibandronate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Ibandronate—Rash—Vincristine—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Ibandronate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Ibandronate—Headache—Vincristine—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Ibandronate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Ibandronate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Ibandronate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Ibandronate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Ibandronate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Ibandronate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Ibandronate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Ibandronate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Ibandronate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Ibandronate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Ibandronate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Ibandronate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000401	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000401	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Ibandronate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Ibandronate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Ibandronate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Ibandronate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Ibandronate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Ibandronate—Rash—Etoposide—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Ibandronate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Ibandronate—Headache—Etoposide—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Ibandronate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Ibandronate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000351	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000349	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000344	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Ibandronate—Infection—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Ibandronate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000322	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000319	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000317	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Ibandronate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Ibandronate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Ibandronate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Ibandronate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Ibandronate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000217	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00021	CcSEcCtD
Ibandronate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Ibandronate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000208	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000203	CcSEcCtD
Ibandronate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000197	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Ibandronate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000194	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000193	CcSEcCtD
Ibandronate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000192	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000182	CcSEcCtD
